LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

Search

CorMedix Inc

Cerrado

SectorSalud

13.57 -2.58

Resumen

Variación precio

24h

Actual

Mínimo

13.39

Máximo

13.6

Métricas clave

By Trading Economics

Ingresos

7.2M

21M

Ventas

7.9M

39M

P/B

Media del Sector

57.36

50.857

BPA

0.299

Margen de beneficio

52.822

Empleados

64

EBITDA

7.2M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+26.76% upside

Dividendos

By Dow Jones

Próximas Ganancias

13 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

351M

988M

Apertura anterior

16.15

Cierre anterior

13.57

Noticias sobre sentimiento de mercado

By Acuity

17%

83%

23 / 381 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

CorMedix Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

18 jun 2025, 17:32 UTC

Principales Movimientos del Mercado

Lion Group Shares Climb on $600 Million Loan for Crypto Treasury

18 jun 2025, 23:55 UTC

Adquisiciones, fusiones, absorciones

Nippon Steel: To Book Restructuring Loss Related to This Sale in 1Q

18 jun 2025, 23:53 UTC

Adquisiciones, fusiones, absorciones

Nippon Steel: NS Kote Is an Entity That Owns All of Company's Equity Stake in AM/NS Calvert

18 jun 2025, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nippon Steel: To Book About Y230B Loss Related to Sale of NS Kote to ArcelorMittal

18 jun 2025, 23:50 UTC

Charlas de Mercado

Australian Uranium Stocks Tipped to Go Higher -- Market Talk

18 jun 2025, 23:43 UTC

Charlas de Mercado

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

18 jun 2025, 23:43 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

18 jun 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

18 jun 2025, 23:07 UTC

Charlas de Mercado

Fletcher Building Recovery May Be More Muted Than Thought -- Market Talk

18 jun 2025, 23:00 UTC

Charlas de Mercado

Smart Glasses Seen as Possible Future Agentic AI Platform -- Market Talk

18 jun 2025, 21:50 UTC

Charlas de Mercado

Argentina Poised To Become Significant LNG Exporter, Rystad Says -- Market Talk

18 jun 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

18 jun 2025, 20:38 UTC

Adquisiciones, fusiones, absorciones

U.S. Steel and Nippon Finalize Their 'Partnership.' What Comes After the Merger. -- Barrons.com

18 jun 2025, 20:32 UTC

Ganancias

These Stocks Moved the Most Today: Tesla, Marvell, Sunrun, Nucor, Circle Internet, Korn Ferry, GMS, and More -- Barrons.com

18 jun 2025, 19:59 UTC

Charlas de Mercado

Oil Edges Up as Next Steps in Iran Conflict Eyed -- Market Talk

18 jun 2025, 19:42 UTC

Charlas de Mercado

Natural Gas Extends Gains for Fourth Session -- Market Talk

18 jun 2025, 19:40 UTC

Ganancias

Fed Holds Rates Steady and Keeps Door Open to Cuts -- 3rd Update

18 jun 2025, 18:47 UTC

Adquisiciones, fusiones, absorciones

Railroads Have Slashed Costs and Raised Prices. Why One CEO Now Favors a Merger. -- Barrons.com

18 jun 2025, 18:33 UTC

Charlas de Mercado

Fitch Says U.S. Fiscal Outlook Remains Challenging -- Market Talk

18 jun 2025, 18:26 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

18 jun 2025, 18:26 UTC

Charlas de Mercado

Nucor, Steel Dynamics Seen Diverging In Approach To Current Business Climate -- Market Talk

18 jun 2025, 18:15 UTC

Charlas de Mercado

Gold Stays Flat After Fed Decision -- Market Talk

18 jun 2025, 17:42 UTC

Adquisiciones, fusiones, absorciones

ArcelorMittal Expects Related 2Q Gain of About $1.5B

18 jun 2025, 17:40 UTC

Adquisiciones, fusiones, absorciones

ArcelorMittal Completes Acquisition of Nippon Steel's 50% Interest in AM/NS Calvert

18 jun 2025, 17:20 UTC

Ganancias

Credit Card Annual Fees Are Going Up. What It Means for the Stocks. -- Barrons.com

18 jun 2025, 16:52 UTC

Charlas de Mercado

Trump Awakens Canada On Need For Fewer Trade Barriers, Macklem Says -- Market Talk

18 jun 2025, 16:31 UTC

Adquisiciones, fusiones, absorciones

Nippon Steel Completes Purchase of U.S. Steel After Reaching Security Deal With Trump Administration -- Update

18 jun 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

18 jun 2025, 16:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

18 jun 2025, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

Comparación entre iguales

Cambio de precio

CorMedix Inc Esperado

Precio Objetivo

By TipRanks

26.76% repunte

Estimación a 12 meses

Media 17.67 USD  26.76%

Máximo 20 USD

Mínimo 13 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

23 / 381 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.